LFC0 Stock Overview
Engages in the research and development of medical sensors for health monitoring in Norway.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
+ 2 more risks
Lifecare AS Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NOK 1.51 |
| 52 Week High | NOK 5.92 |
| 52 Week Low | NOK 1.18 |
| Beta | -0.22 |
| 11 Month Change | 18.13% |
| 3 Month Change | 1.55% |
| 1 Year Change | -34.96% |
| 33 Year Change | -41.11% |
| 5 Year Change | n/a |
| Change since IPO | -61.28% |
Recent News & Updates
Recent updates
Shareholder Returns
| LFC0 | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | -7.4% | -1.3% | 0.02% |
| 1Y | -35.0% | 8.2% | 19.6% |
Return vs Industry: LFC0 underperformed the German Medical Equipment industry which returned 8.2% over the past year.
Return vs Market: LFC0 underperformed the German Market which returned 19.6% over the past year.
Price Volatility
| LFC0 volatility | |
|---|---|
| LFC0 Average Weekly Movement | 23.2% |
| Medical Equipment Industry Average Movement | 5.3% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 11.4% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: LFC0's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: LFC0's weekly volatility (23%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | 32 | Joacim Holter | www.lifecare.no |
Lifecare AS engages in the research and development of medical sensors for health monitoring in Norway. The company develops Sencell, a micro sensor for monitoring glucose levels in patients with diabetes. It manufactures and develops nanostrain biosensors for measuring pressure and temperature in live tissue.
Lifecare AS Fundamentals Summary
| LFC0 fundamental statistics | |
|---|---|
| Market cap | €24.09m |
| Earnings (TTM) | -€4.21m |
| Revenue (TTM) | €1.36m |
17.7x
P/S Ratio-5.7x
P/E RatioIs LFC0 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| LFC0 income statement (TTM) | |
|---|---|
| Revenue | NOK 16.10m |
| Cost of Revenue | NOK 0 |
| Gross Profit | NOK 16.10m |
| Other Expenses | NOK 65.93m |
| Earnings | -NOK 49.84m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Nov 13, 2024
| Earnings per share (EPS) | -3.14 |
| Gross Margin | 100.00% |
| Net Profit Margin | -309.61% |
| Debt/Equity Ratio | 0% |
How did LFC0 perform over the long term?
See historical performance and comparison